secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIZYME, INC. (—)
CIK:        0001413754
Form:       8-K
Filed at:   2023-11-21T23:59:59+00:00
Accession:  0001493152-23-042333
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marizyme completes fifth closing of OID unit private placement, raises $550,000 cash
--------------------------------------------------------------------------------

- Issued $647,062 principal amount of 15% OID convertible notes convertible at $0.10 per share to six investors for $550,000 cash.
- Also issued Class E warrants (8.1M shares at $0.10) and Class F warrants (8.1M shares at $0.20) to the same investors.
- Cancelled $150,319 of short-term debt to three consultants by issuing $176,847 principal amount of notes and equivalent warrants.
- Net cash proceeds after 8% placement agent fee to Univest Securities were $506,000; no fee on debt cancellation.
- Notes mature August 20, 2024; warrants exercisable for five years; registration rights waived by all investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1413754/000149315223042333/0001493152-23-042333-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1413754/000149315223042333/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-042333

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer